Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033

Description

Transthyretin amyloidosis (ATTR) treatment refers to the medical treatments aimed at managing transthyretin amyloidosis, a progressive, life-threatening disease resulting from misfolded transthyretin proteins that form amyloid deposits in tissues. The condition arises due to familial or spontaneous mutations that destabilize transthyretin protein, causing aggregation and deposition of fibers in various tissues. This rare condition primarily affects the peripheral nerves, heart and other organs, with the two main forms being polyneuropathy (nerve damage) and cardiomyopathy (heart muscle disease).

The ATTR treatment market consists of sales by entities (organizations, sole traders and partnerships) of ATTR treatment drugs that are essential for controlling the disease's progression, managing symptoms and improving the quality of life for affected patients, as untreated cases can lead to significant morbidity and reduced life expectancy.

The global transthyretin amyloidosis treatment market was valued at $149.12 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 95.00%.

Increasing Adoption Of Personalized Medicine

The increasing adoption of personalized medicine propelled the growth of the ATTR treatment market. The adoption of personalized medicine has accelerated the development of novel therapeutics specifically designed to address the molecular causes of transthyretin amyloidosis (ATTR). These targeted treatments typically offer improved efficacy and reduced side effects compared to conventional therapies, making them more appealing to patients and driving increased market growth. For instance, in October 2022, according to the Personalized Medicine Coalition(PMC), a US-based organization that represents scientists, patients and providers, promoting the understanding and adoption of personalized medicine to benefit patients and the healthcare system, more than 75,000 genetic testing products and 300 personalized medicines were present on the market for people with multiple types of cancers, genetic rare diseases and a range of chronic and infectious diseases. Additionally, personalized medicines accounted for 34% of new drug approvals by the US Food and Drug Administration in 2022 and have accounted for at least 25% of approvals in each of the previous eight years. Therefore, the increasing adoption of personalized medicine supported the growth of the ATTR treatment market during the historic period.

The global ATTR treatment market is concentrated, with large players operating in the market. The top three competitors in the market made up to 100.00% of the total market in 2023.

Transthyretin Amyloidosis Treatment Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global transthyretin amyloidosis treatment market as it emerges from the COVID-19 shut down.

Reasons to Purchase:

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for transthyretin amyloidosis treatment? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The transthyretin amyloidosis treatment market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider transthyretin amyloidosis treatment market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by drug and by distribution channel.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario - The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the transthyretin amyloidosis treatment market.

Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

Regional And Country Analysis - Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation - Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by drug and by distribution channel in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
Regional Market Size and Growth - Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for transthyretin amyloidosis treatment providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Type: Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM); Transthyretin Amyloidosis With Polyneuropathy (ATTR-PN)
2) By Drug: Tafamidis; Patisiran; Inotersen; Other Drugs
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Companies Mentioned: Pfizer Inc.; Alnylam Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; BridgeBio Pharma, Inc.; Intellia Therapeutics Inc.
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; transthyretin amyloidosis treatment indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: o&s1443

1 Executive Summary

1.1 Transthyretin Amyloidosis Treatment - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 Transthyretin Amyloidosis Treatment Market Definition And Segmentations
6.4 Market Segmentation By Type
- 6.4.1 Transthyretin Amyloidosis With Polyneuropathy
- 6.4.2 Transthyretin Amyloidosis With Cardiomyopathy
6.5 Market Segmentation By Drug
- 6.5.1 Tafamidis
- 6.5.2 Patisiran
- 6.5.3 Inotersen
- 6.5.4 Other Drugs
6.6 Market Segmentation By Distribution Channel
- 6.6.1 Hospital Pharmacies
- 6.6.2 Retail Pharmacies
- 6.6.3 Online Pharmacies

7 Major Market Trends

7.1 Advancing Treatment Options For Amyloidosis With Novel Therapeutic Antibody

8 Transthyretin Amyloidosis Treatment Market - Macro Economic Scenario

8.1 COVID-19 Impact On The Transthyretin Amyloidosis Treatment Market
8.2 Impact Of The War In Ukraine On The Transthyretin Amyloidosis Treatment Market
8.3 Impact Of High Inflation On The Transthyretin Amyloidosis Treatment Market

9 Global Market Size and Growth

9.1 Market Size
9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
- 9.2.1 Market Drivers 2018 - 2023
- 9.2.2 Market Restraints 2018 - 2023
9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
- 9.3.1 Market Drivers 2023 - 2028
- 9.3.2 Market Restraints 2023 - 2028

10 Global Transthyretin Amyloidosis Treatment Market Segmentation

10.1 Global Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.2 Global Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.3 Global Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Transthyretin Amyloidosis Treatment Market, Regional and Country Analysis

11.1 Global Transthyretin Amyloidosis Treatment Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.2 Global Transthyretin Amyloidosis Treatment Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

12.1 Summary
12.2 Market Overview
- 12.2.1 Region Information
- 12.2.2 Market Information
- 12.2.3 Background Information
- 12.2.4 Government Initiatives
- 12.2.5 Regulations
- 12.2.6 Regulatory Bodies
- 12.2.7 Major Associations
- 12.2.8 Taxes Levied
- 12.2.9 Corporate Tax Structure
- 12.2.10 Investments
- 12.2.11 Major Companies
12.3 Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.4 Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.5 Asia Pacific Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.6 China Market
12.7 Summary
12.8 Market Overview
- 12.8.1 Country Information
- 12.8.2 Market Information
- 12.8.3 Background Information
- 12.8.4 Government Initiatives
- 12.8.5 Regulations
- 12.8.6 Regulatory Bodies
- 12.8.7 Major Associations
- 12.8.8 Taxes Levied
- 12.8.9 Corporate Tax Structure
- 12.8.10 Major Companies
12.9 China Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.10 China Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.11 China Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.12 India Market
12.13 India Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.14 India Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.15 India Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.16 Japan Market
12.17 Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.18 Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.19 Japan Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.20 Australia Market
12.21 Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.22 Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.23 Australia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.24 Indonesia Market
12.25 Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.26 Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.27 Indonesia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.28 South Korea Market
12.29 South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.30 South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.31 South Korea Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

13.1 Summary
13.2 Market Overview
- 13.2.1 Region Information
- 13.2.2 Market Information
- 13.2.3 Background Information
- 13.2.4 Government Initiatives
- 13.2.5 Regulations
- 13.2.6 Regulatory Bodies
- 13.2.7 Major Associations
- 13.2.8 Taxes Levied
- 13.2.9 Corporate tax structure
- 13.2.10 Investments
- 13.2.11 Major Companies
13.3 Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.5 Western Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.6 Western Europe Transthyretin Amyloidosis Treatment Market: Country Analysis
13.7 UK Market
13.8 UK Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.9 UK Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.10 UK Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.11 Germany Market
13.12 Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.13 Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.14 Germany Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.15 France Market
13.16 France Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.17 France Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.18 France Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.19 Italy Market
13.20 Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.21 Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.22 Italy Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.23 Spain Market
13.24 Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.25 Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.26 Spain Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

14.1 Summary
14.2 Market Overview
- 14.2.1 Region Information
- 14.2.2 Market Information
- 14.2.3 Background Information
- 14.2.4 Government Initiatives
- 14.2.5 Regulations
- 14.2.6 Regulatory Bodies
- 14.2.7 Major Associations
- 14.2.8 Taxes Levied
- 14.2.9 Corporate Tax Structure
- 14.2.10 Investments
- 14.2.11 Major companies
14.3 Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.6 Eastern Europe Transthyretin Amyloidosis Treatment Market: Country Analysis
14.7 Russia Market
14.8 Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.9 Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.10 Russia Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

15.1 Summary
15.2 Market Overview
- 15.2.1 Region Information
- 15.2.2 Market Information
- 15.2.3 Background Information
- 15.2.4 Government Initiatives
- 15.2.5 Regulations
- 15.2.6 Regulatory Bodies
- 15.2.7 Major Associations
- 15.2.8 Taxes Levied
- 15.2.9 Corporate Tax Structure
- 15.2.10 Investments
- 15.2.11 Major Companies
15.3 North America Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.4 North America Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.5 North America Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.6 North America Transthyretin Amyloidosis Treatment Market: Country Analysis
15.7 USA Market
15.8 Summary
15.9 Market Overview
- 15.9.1 Country Information
- 15.9.2 Market Information
- 15.9.3 Background Information
- 15.9.4 Government Initiatives
- 15.9.5 Regulations
- 15.9.6 Regulatory Bodies
- 15.9.7 Major Associations
- 15.9.8 Taxes Levied
- 15.9.9 Corporate Tax Structure
- 15.9.10 Investments
- 15.9.11 Major Companies
15.10 USA Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.11 USA Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.12 USA Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.13 Canada Market
15.14 Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.15 Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.16 Canada Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

16.1 Summary
16.2 Market Overview
- 16.2.1 Region Information
- 16.2.2 Market Information
- 16.2.3 Background Information
- 16.2.4 Government Initiatives
- 16.2.5 Regulations
- 16.2.6 Regulatory Bodies
- 16.2.7 Major Associations
- 16.2.8 Taxes Levied
- 16.2.9 Corporate Tax Structure
- 16.2.10 Investments
- 16.2.11 Major Companies
16.3 South America Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.4 South America Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.5 South America Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.6 South America Transthyretin Amyloidosis Treatment Market: Country Analysis
16.7 Brazil Market
16.8 Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.10 Brazil Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

17.1 Summary
17.2 Market Overview
- 17.2.1 Region Information
- 17.2.2 Market Information
- 17.2.3 Background Information
- 17.2.4 Government Initiatives
- 17.2.5 Regulations
- 17.2.6 Regulatory Bodies
- 17.2.7 Major Associations
- 17.2.8 Taxes Levied
- 17.2.9 Corporate Tax Structure
- 17.2.10 Major Companies
17.3 Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.5 Middle East Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

18.1 Summary
18.2 Market Overview
- 18.2.1 Region Information
- 18.2.2 Market Information
- 18.2.3 Background Information
- 18.2.4 Government Initiatives
- 18.2.5 Regulations
- 18.2.6 Regulatory Bodies
- 18.2.7 Major Associations
- 18.2.8 Taxes Levied
- 18.2.9 Major Companies
18.3 Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.4 Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Drug, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.5 Africa Transthyretin Amyloidosis Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

19.1 Company Profiles
19.2 Pfizer Inc
- 19.2.1 Company Overview
- 19.2.2 Products And Services
- 19.2.3 Business Strategy
- 19.2.4 Financial Overview
19.3 Alnylam Pharmaceuticals, Inc
- 19.3.1 Company Overview
- 19.3.2 Products And Services
- 19.3.3 Business Strategy
- 19.3.4 Financial Overview
19.4 Ionis Pharmaceuticals, Inc
- 19.4.1 Company Overview
- 19.4.2 Products And Services
- 19.4.3 Business Strategy
- 19.4.4 Financial Overview
19.5 BridgeBio Pharma, Inc
- 19.5.1 Company Overview
- 19.5.2 Products And Services
- 19.5.3 Business Strategy
19.6 Intellia Therapeutics Inc
- 19.6.1 Company Overview
- 19.6.2 Products And Services
- 19.6.3 Business Strategy

20 Other Major And Innovative Companies

20.1 AstraZeneca
- 20.1.1 Company Overview
- 20.1.2 Products And Services
20.2 Novo Nordisk A/S
- 20.2.1 Company Overview
- 20.2.2 Products And Services
20.3 PTC Therapeutics Inc.
- 20.3.1 Company Overview
- 20.3.2 Products And Services
20.4 Bristol-Myers Squibb Company
- 20.4.1 Company Overview
- 20.4.2 Products And Services
20.5 Abbvie Inc.
- 20.5.1 Company Overview
- 20.5.2 Products And Services
20.6 SOM Biotech
- 20.6.1 Company Overview
- 20.6.2 Products And Services
20.7 Corino Therapeutics Inc.
- 20.7.1 Company Overview
- 20.7.2 1.7.2 Products And Services
20.8 Acrotech Biopharma Inc.
- 20.8.1 Company Overview
- 20.8.2 Products And Services
20.9 Neurimmune AG
- 20.9.1 Company Overview
- 20.9.2 Products And Services
20.10 Sorrento Therapeutics, Inc.
- 20.10.1 Company Overview
- 20.10.2 Products And Services
20.11 Oncopeptides AB
- 20.11.1 Company Overview
- 20.11.2 Products And Services
20.12 Takeda Pharmaceutical Company Limited
- 20.12.1 Company Overview
- 20.12.2 Products And Services
20.13 Astellas Pharma, Inc.
- 20.13.1 Company Overview
- 20.13.2 Products And Services
20.14 GSK plc
- 20.14.1 Company Overview
- 20.14.2 Products And Services
20.15 Bausch Health Company
- 20.15.1 Company Overview
- 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

23.1 Astellas Pharma Acquired Polyphor International
23.2 AstraZeneca Acquired Caelum Biosciences
23.3 Novo Nordisk Acquired Prothena Corporation

24 Opportunities And Strategies

24.1 Global Transthyretin Amyloidosis Treatment Market In 2028 - Countries Offering Most New Opportunities
24.2 Global Transthyretin Amyloidosis Treatment Market In 2028 - Segments Offering Most New Opportunities
24.3 Global Transthyretin Amyloidosis Treatment Market In 2028 - Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies

25 Transthyretin Amyloidosis Treatment Market, Conclusions And Recommendations

25.1 Conclusions
25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People

26 Appendix

26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer